Cancer Types
Skin CancerLung CancerBreast CancerProstate Cancer
Colorectal CancerBladder CancerOvarian CancerCervical Cancer
Uterine (Endometrial) CancerLiver & Kidney CancersReproductive CancersPancreatic Cancer
Leukemia & LymphomaBrain & CNS CancersRare Cancers
Consultation Service
Choosing a DoctorTreatment Plan EvaluationGet Your Questions Answered
Obtaining Advanced DiagnosticsIdentifying Clinical TrialsExploring Holistic Approaches
Consultation Overview
ResourcesAbout
Get Started
< All Resources
No items found.

MSI-H/MMR: An Essential Guide for Cancer Patients

Understanding the Basics: What are MSI-H and MMR?

Microsatellite Instability-High (MSI-H) and Mismatch Repair (MMR) are two critical concepts in the field of oncology. To understand them, think of your DNA as a long, complex sentence. This sentence is constantly being copied within your cells, and sometimes, mistakes or "typos" occur during this copying process. These "typos" in the DNA sequence are what we refer to as microsatellites.

MSI-H refers to a condition where these "typos" become frequent and the DNA sequences become unstable. On the other hand, MMR is like the body's personal proofreader. It's a system within our cells that corrects these "typos" to maintain the stability and integrity of our DNA.

The Role of MSI-H in Cancer

When the MMR system fails or is deficient, it can lead to MSI-H. This is akin to having a proofreader who's fallen asleep on the job, allowing the "typos" to accumulate. This instability in the DNA sequences can result in mutations that promote cancer growth.

The Function of MMR in Cancer

The MMR system plays a crucial role in preventing cancer by maintaining the integrity of our DNA. However, when this system is deficient, it can lead to the development of MSI-H, increasing the risk of cancer.

The Importance of MSI-H/MMR Testing

Who Should Get Tested?

MSI or MMR testing is recommended for all types of colorectal cancer. However, it can also be beneficial for other types of cancer, given the role of MSI-H/MMR in cancer development.

How is the Testing Done?

Testing for MSI can be done through two main methods: immunology and genetic testing.

Immunology testing involves examining the proteins produced by the MMR genes. If these proteins are absent or not functioning correctly, it can indicate a problem with the MMR system.

Genetic testing, on the other hand, looks directly at the DNA. It checks for specific changes or mutations in the MMR genes that can lead to a deficiency in the MMR system.

Requesting MSI-H/MMR Testing from Your Oncologist

If you are a cancer patient, you can request MSI-H/MMR testing from your oncologist. This test is also done as a part of Next-Generation tumor sequencing, which can be ordered by your oncologist. This comprehensive test can provide valuable information about the genetic makeup of your tumor, including your MSI-H/MMR status.

The Prognostic Value of MSI-H/MMR

MSI-H/MMR and Survival Rates

Patients with MSI-H tumors often have a better prognosis than patients with Microsatellite Stable (MSS) tumors. This is because MSI-H tumors often have a higher mutational load, which can make them more responsive to certain treatments.

MSI-H/MMR and Treatment Response

MSI-H/MMR status can also influence a patient's response to treatment. For instance, MSI-H/MMR deficient tumors have been found to respond well to immunotherapy, a type of treatment that boosts the body's natural defenses to fight cancer.

MSI-H/MMR and Treatment Options

Traditional Cancer Treatments

Traditional cancer treatments such as chemotherapy and radiation therapy can be effective for many patients. However, the effectiveness of these treatments can vary depending on the patient's MSI-H/MMR status.

Immunotherapy and MSI-H/MMR

Immunotherapy has emerged as a promising treatment option for patients with MSI-H/MMR deficient tumors. This is because these tumors often have a high mutational load, which can make them more visible to the immune system.

MSI-H/MMR in Clinical Trials

The Impact of MSI-H/MMR on Clinical Trials

MSI-H and MMR are being used in many clinical trials to explore new treatment options for cancer patients. These trials are not limited to colorectal cancer but extend to various other types of cancer as well. The goal is to find more effective treatments that can improve the prognosis and quality of life for cancer patients.

A Case Study: The Unexpected Results of a Rectal Cancer Trial

A recent clinical trial involving 18 rectal cancer patients demonstrated the potential of MSI-H/MMR testing in transforming cancer treatment. In this trial, every patient was given a drug called dostarlimab, a type of checkpoint inhibitor, as the first line of treatment instead of surgery, chemotherapy, and radiation. Astonishingly, the cancer vanished in every single patient, undetectable by physical exam, endoscopy, PET scans, or MRI scans. This unexpected result has sparked hope and excitement in the field of oncology, highlighting the potential of MSI-H/MMR testing in improving cancer treatment outcomes.

MSI-H/MMR and Hereditary Risk

Testing Family Members for MSI-H/MMR

Deficiencies in DNA mismatch repair (dMMR) can be caused by hereditary, germline mutations. This means that individuals with a family history of certain cancers may have an increased risk of developing MSI-H/MMR deficient tumors. Family members of patients with these types of tumors can also be tested for MSI-H/MMR. If they test positive, they may need to undergo heightened cancer screening to detect any potential cancers early.

Conclusion

Understanding MSI-H/MMR is crucial for cancer patients as it can influence prognosis, treatment response, and even hereditary risk. By staying informed, patients can better navigate their treatment options and make more informed decisions about their care.

FAQs

  1. What is MSI-H?
    ‍
    MSI-H stands for Microsatellite Instability-High, a condition where DNA sequences become unstable due to errors in DNA replication.
    ‍
  2. What is MMR?
    ‍
    MMR stands for Mismatch Repair, a system within our cells that corrects errors in DNA to maintain its stability.
    ‍
  3. Who should get tested for MSI-H/MMR?
    ‍
    MSI-H/MMR testing is recommended for all types of colorectal cancer and can also be beneficial for other types of cancer.
    ‍
  4. What is the significance of MSI-H/MMR in cancer treatment?
    ‍
    MSI-H/MMR status can influence a patient's prognosis and response to treatment, including the effectiveness of immunotherapy.
    ‍
  5. Does MSI-H/MMR status indicate a hereditary risk?
    ‍
    Yes, deficiencies in DNA mismatch repair (dMMR) can be caused by hereditary, germline mutations, indicating an increased risk of developing MSI-H/MMR deficient tumors.

Further Reading:

  • New York Times Article: A Cancer Trial’s Unexpected Result: Remission in Every Patient
    ‍
  • Sagely Health Article: Requesting NextGen Tumor Sequencing
    ‍
  • PubMed (Advanced Biomedical Research): Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer
  • Frontiers in Genetics: The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers

Register to Attend Online (Free)

You'll be able to join live while we record.
You are all registered!

You will get an email with all the information you'll need to connect.

We look forward to seeing you!
Oops! Something went wrong while submitting the form.

QUICK LINKS

RECENT POSTS

Supporting a Parent Through Cancer: Guidance, Tips, and Hope
How Does Your Oncologist Choose Cancer Treatments?
Understanding Cancer Clinical Trials: Navigating Your Options with Confidence
How to Choose the Right Oncologist or Cancer Surgeon
Advanced Cancer Diagnostics: Transforming Treatment Decisions
Debunking Cancer Myths: Insights on Cures, Trials, and Treatments
Webinar: Hope for Hard-to-Treat Cancers
BRCA. It's not just about breast cancer anymore.
Cancer’s Magic Bullet: Antibody Drug Conjugates
Cancer Vaccine Breakthrough - A Spark and Promising Results for Pancreatic Adenocarcinoma Patients
See All Posts

MORE RESOURCES

Join Mailing List

Video

Video

Supporting a Parent Through Cancer: Guidance, Tips, and Hope

Learn practical frameworks to help an aging parent navigate cancer care—from risk ranking to building the right medical team.

Video

Video

How Does Your Oncologist Choose Cancer Treatments?

Learn how oncologists evaluate cancer treatment options, from following NCCN Guidelines and FDA approvals to considering clinical trials and insurance coverage.

Article

Article

Cancer’s Magic Bullet: Antibody Drug Conjugates

An in-depth look at Antibody Drug Conjugates (ADCs), a groundbreaking innovation that has significantly expanded treatment possibilities for many cancer patients.

GUIDE

Medical Records Guide for Cancer Patients

If you are getting a second opinion from an oncologist (hopefully one that has innovative treatments to offer), it is important that you gather and provide the necessary medical records.

See All Resources

5 Days. More Clarity. Better Questions.

Our Free Email Series to Help You Take Control of Your Cancer Treatment

Most patients are handed a treatment plan and told to begin. But what if there are better options—or steps being missed?

This free 5-day email series helps you understand the hidden opportunities that could shape your care. It covers what many patients wish they had known sooner—before key decisions were made.

You’ll get insights on:

What roles your care team should be playing
How advanced testing and tumor sequencing uncover crucial details
When to explore clinical trials (and what they actually offer)
Why second opinions aren’t just for worst-case scenarios
How to avoid common mistakes and missed opportunities

Each short email builds on the last, helping you feel more informed and in control—right when decisions matter most.

Start Getting Clarity—One Email at a Time

Join hundreds of patients gaining clarity and confidence—in just 5 short emails.

HIPAA Compliant
Thanks for signing up for our free email series. The first email is on the way!
No spam. No pressure. Just thoughtful guidance from experts who’ve helped hundreds of patients.
Oops! Something went wrong while submitting the form.
Our mission is to ensure every cancer patient achieves their best possible outcome.
Let's Talk
Learn About Our Consultation
Attend an Informational Session
Start Your Consultation
1 (844) 724-3591
info@sagelyhealth.com
Join Mailing List
Resources
Videos and Articles
Free 5-Day Email Series
Medical Record Guide
Terms | Privacy
Copyright © 2025 Sagely Health, LLC. All rights reserved.